These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 23137583

  • 1. Comparative safety of therapies in systemic lupus erythematosus.
    Mosak J, Furie R.
    Rheum Dis Clin North Am; 2012 Nov; 38(4):795-807. PubMed ID: 23137583
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Emerging biological therapies in systemic lupus erythematosus.
    Mount GR, Gilliland WR.
    Clin Pharmacol Ther; 2008 Jan; 83(1):167-71. PubMed ID: 18000515
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy of antimalarials in systemic lupus erythematosus.
    Esdaile JM.
    Lupus; 1993 Feb; 2 Suppl 1():S3-8. PubMed ID: 8485568
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of antimalarials in systemic lupus erythematosus.
    Nayak V, Esdaile JM.
    Lupus; 1996 Jun; 5 Suppl 1():S23-7. PubMed ID: 8803906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Diagnosis and Treatment of Systemic Lupus Erythematosus.
    Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M.
    Dtsch Arztebl Int; 2015 Jun 19; 112(25):423-32. PubMed ID: 26179016
    [Abstract] [Full Text] [Related]

  • 10. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K.
    J Rheumatol; 2004 Nov 19; 31(11):2156-62. PubMed ID: 15517627
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patterns of medication use before, during and after pregnancy in women with systemic lupus erythematosus: a population-based cohort study.
    Zusman EZ, Sayre EC, Aviña-Zubieta JA, De Vera MA.
    Lupus; 2019 Sep 19; 28(10):1205-1213. PubMed ID: 31311418
    [Abstract] [Full Text] [Related]

  • 13. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
    Merrill JT, Wallace DJ, Petri M, Kirou KA, Yao Y, White WI, Robbie G, Levin R, Berney SM, Chindalore V, Olsen N, Richman L, Le C, Jallal B, White B, Lupus Interferon Skin Activity (LISA) Study Investigators.
    Ann Rheum Dis; 2011 Nov 19; 70(11):1905-13. PubMed ID: 21798883
    [Abstract] [Full Text] [Related]

  • 14. Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population.
    Hardy C, Gladman DD, Su J, Rozenbojm N, Urowitz MB.
    Rheumatol Int; 2021 Aug 19; 41(8):1457-1464. PubMed ID: 34089358
    [Abstract] [Full Text] [Related]

  • 15. Medication use in systemic lupus erythematosus.
    Bernatsky S, Peschken C, Fortin PR, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS).
    J Rheumatol; 2011 Feb 19; 38(2):271-4. PubMed ID: 21078722
    [Abstract] [Full Text] [Related]

  • 16. [Aggressive therapy of highly active systemic lupus erythematosus].
    Graninger W.
    Acta Med Austriaca; 1996 Feb 19; 23(4):129-33. PubMed ID: 9036724
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management and prognosis of systemic lupus erythematosus.
    Dubois EL.
    Bull Rheum Dis; 1967 Nov 19; 18(3):477-82. PubMed ID: 4868664
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.